» Articles » PMID: 2555787

RNase H Cleavage of RNA Hybridized to Oligonucleotides Containing Methylphosphonate, Phosphorothioate and Phosphodiester Bonds

Overview
Specialty Biochemistry
Date 1989 Nov 25
PMID 2555787
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Three types of 14-mer oligonucleotides were hybridized to human beta-globin pre-mRNA and the resultant duplexes were tested for susceptibility to cleavage by RNase H from E. coli or from HeLa cell nuclear extract. The oligonucleotides contained normal deoxynucleotides, phosphorothioate analogs alternating with normal deoxynucleotides, or one to six methylphosphonate deoxynucleosides. Duplexes formed with deoxyoligonucleotides or phosphorothioate analogs were susceptible to cleavage by RNase H from both sources, whereas a duplex formed with an oligonucleotide containing six methylphosphonate deoxynucleosides alternating with normal deoxynucleotides was resistant. Susceptibility to cleavage by RNase H increased parallel to a reduction in the number of methylphosphonate residues in the oligonucleotide. Stability of the oligonucleotides in the nuclear extract from HeLa cells was also tested. Whereas deoxyoligonucleotides were rapidly degraded, oligonucleotides containing alternating methylphosphonate residues remained unchanged after 70 minutes of incubation. Other oligonucleotides exhibited intermediate stability.

Citing Articles

Application of antisense oligonucleotide drugs in amyotrophic lateral sclerosis and Huntington's disease.

Ou K, Jia Q, Li D, Li S, Li X, Yin P Transl Neurodegener. 2025; 14(1):4.

PMID: 39838446 PMC: 11748355. DOI: 10.1186/s40035-025-00466-9.


Exploring the therapeutic potential of sγPNA-141: Pharmacodynamics and mechanistic insights during ischemic stroke recovery.

Yadav S, Dhuri K, Gamiotea-Turro D, Cormier M, Patel V, Yadawa A Mol Ther Nucleic Acids. 2024; 35(4):102355.

PMID: 39507400 PMC: 11539414. DOI: 10.1016/j.omtn.2024.102355.


Unlocking the therapeutic potential of locked nucleic acids through lipid nanoparticle delivery.

Qassem S, Breier D, Somu Naidu G, Hazan-Halevy I, Peer D Mol Ther Nucleic Acids. 2024; 35(2):102224.

PMID: 38933259 PMC: 11201112. DOI: 10.1016/j.omtn.2024.102224.


Unwinding the SARS-CoV-2 Ribosomal Frameshifting Pseudoknot with LNA and G-Clamp-Modified Phosphorothioate Oligonucleotides Inhibits Viral Replication.

Knizhnik E, Chumakov S, Svetlova J, Pavlova I, Khodarovich Y, Brylev V Biomolecules. 2023; 13(11).

PMID: 38002341 PMC: 10668963. DOI: 10.3390/biom13111660.


Enhancing Antisense Oligonucleotide-Based Therapeutic Delivery with DG9, a Versatile Cell-Penetrating Peptide.

Haque U, Yokota T Cells. 2023; 12(19).

PMID: 37830609 PMC: 10572411. DOI: 10.3390/cells12192395.


References
1.
Stein C, Cohen J . Oligodeoxynucleotides as inhibitors of gene expression: a review. Cancer Res. 1988; 48(10):2659-68. View

2.
Cazenave C, Chevrier M, Nguyen T, Helene C . Rate of degradation of [alpha]- and [beta]-oligodeoxynucleotides in Xenopus oocytes. Implications for anti-messenger strategies. Nucleic Acids Res. 1987; 15(24):10507-21. PMC: 339959. DOI: 10.1093/nar/15.24.10507. View

3.
Shuttleworth J, Colman A . Antisense oligonucleotide-directed cleavage of mRNA in Xenopus oocytes and eggs. EMBO J. 1988; 7(2):427-34. PMC: 454337. DOI: 10.1002/j.1460-2075.1988.tb02830.x. View

4.
Stein C, Subasinghe C, Shinozuka K, Cohen J . Physicochemical properties of phosphorothioate oligodeoxynucleotides. Nucleic Acids Res. 1988; 16(8):3209-21. PMC: 336489. DOI: 10.1093/nar/16.8.3209. View

5.
Maher 3rd L, Dolnick B . Comparative hybrid arrest by tandem antisense oligodeoxyribonucleotides or oligodeoxyribonucleoside methylphosphonates in a cell-free system. Nucleic Acids Res. 1988; 16(8):3341-58. PMC: 336498. DOI: 10.1093/nar/16.8.3341. View